Research Summaries

FDA Alert
FDA Alert
04/22/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA previously approved lisocabtagene maraleucel as a second-line treatment option for adult patients with large B-cell lymphoma in June 2022.
04/22/2024
Research Summary
Research Summary
02/07/2024
Anthony Calabro, MA
Using data from observational and clinical trials, researchers examined the association between advancements in metastatic breast cancer treatment and the observed improvement in breast cancer mortality...
02/07/2024
Research Summary
Research Summary
05/09/2023
The US Preventive Services Task Force (USPSTF) issued a draft recommendation regarding breast cancer screening in women aged 40 years old to 74 years old.
05/09/2023
Research summary
Research summary
04/29/2023
Jessica Ganga
A group of researchers aimed to determine the incidence rate of brain metastases in patients with metastatic uveal melanoma using data from comprehensive cancer centers.
04/29/2023
Conference Coverage
Conference Coverage
04/21/2023
Jessica Ganga
Researchers evaluated the response rate of gemcitabine in patients with platinum-resistant ovarian cancer given at a low dosage. Their research was presented at the Hematology/Oncology Pharmacy...
04/21/2023
Research Summary
Research Summary
02/23/2023
The American Heart Association (AHA) addresses the adverse effect of hypertension in patients receiving anticancer therapies and how the disease should be managed.
02/23/2023
Research Summary
research summary
Research Summary
02/10/2023
The researchers examined the mortality risks of bariatric surgery compared with patients who did not undergo surgery using 40-year follow-up.
02/10/2023
Bladder Cancer
Bladder Cancer
01/04/2023
The FDA’s approval of the first gene therapy to treat high-risk non-muscle-invasive bladder cancer follow a multicenter clinical trial.
01/04/2023
Cancer Pain
Cancer Pain
09/28/2022
The recommendations include effective forms of therapy to help manage common symptoms associated with cancer such as joint pain.
09/28/2022
Oncology
Oncology
06/27/2022
Researchers examined the impact of protein-energy malnutrition on the risk of death in patients with diffuse large B-cell lymphoma who are undergoing chemotherapy.
06/27/2022